tirzepatide in hfpef SUMMIT: a 'Huge Win' for Patients With Obesity Tirzepatide benefits obese HFpEF patients

GLP-1 (glucagon-like peptide-1) receptor agonists form a class of medications that clinicians originally developed to help manage type 2 diabetes

These medications bind with GLP-1 receptors to boost your bodys built-in system for appetite, digestion, and glucose balanceone reason theyre so effective for weight loss and diabetes management

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

This guide covers everything you need to build a tracking system that actually works

However, you may only start to notice its effects after a few weeks or months